Skip to main content
. 2026 Oct 2;18(19):3181. doi: 10.3390/cancers18193181
TNBC Triple-negative breast cancer
ER Estrogen receptor
PR Progesterone receptor
HER2 Human epithelial growth factor receptor 2
PARP Poly ADP ribose polymerase
BL1 Basal-like 1
BL2 Basal-like 2
IM Immunomodulatory
M Mesenchymal
MSL Mesenchymal stem-like
LAR Luminal androgen receptor
EMT Epithelial–mesenchymal transition
OS Overall survival
DFS Disease-free survival
ABCC9 ATP-binding cassette subfamily C member 9
NKAPL NF-Kβ-activating protein-;ike
MiRNA MicroRNA
ARRB1 Arrestin beta 1
lncRNA Long non-coding RNA
DNMT3A DNA methyltransferase 3α
EZH2 Enhancer of zeste homolog 2
PKM2 Pyruvate kinase M2
EGFR Epidermal growth factor receptor
VEGF Vascular endothelial growth factor
PD-L1 Programmed death ligand-1
TIL Tumor infiltrating lymphocyte
ITPKC Inositol 1,4,5-trisphosphate 3-kinase C
CTC Circulating tumor cell
cfDNA Circulating cell-free DNA
ctDNA Circulating tumor DNA
EVs Extracellular vesicles
IGF-IR Insulin-like growth factor 1 receptor (IGF-IR)
MMP-2 Matrix metalloproteinase-2
MMP-9 Matrix metalloproteinase-9
LAG-3 Lymphocyte activation gene 3
IHC Immunohistochemistry
TIM-3 T-cell immunoglobulin and mucin-domain containing protein 3
TCGA The Cancer Genome Atlas